Lucid Diagnostics Inc (LUCD) — Cash Flow-to-Debt Ratio
Lucid Diagnostics Inc (LUCD) has a Cash Flow-to-Debt Ratio of -0.43x as of December 2025, meaning its operating cash flow of $-12.58 Million could theoretically repay 0% of its total liabilities ($29.51 Million) in one year. See working capital position of Lucid Diagnostics Inc to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lucid Diagnostics Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Lucid Diagnostics Inc across 8 annual periods. Also explore Lucid Diagnostics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Lucid Diagnostics Inc (2018–2025)
Year-by-year debt coverage analysis for Lucid Diagnostics Inc. For market capitalisation and broader financial context, see Lucid Diagnostics Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1575.28x | $-46.48 Billion | $29.51 Million | ▼ -90277.1% |
| 2024 | -1.74x | $-44.14 Million | $25.32 Million | ▼ -57.1% |
| 2023 | -1.11x | $-32.82 Million | $29.58 Million | ▲ +64.6% |
| 2022 | -3.14x | $-29.68 Million | $9.46 Million | ▲ +24.4% |
| 2021 | -4.15x | $-17.67 Million | $4.26 Million | ▼ -1057.8% |
| 2020 | -0.36x | $-5.63 Million | $15.71 Million | ▲ +3.8% |
| 2019 | -0.37x | $-2.36 Million | $6.34 Million | ▼ -253.8% |
| 2018 | -0.11x | $-113.70K | $1.08 Million | — |